1-3 of 3
David M. Sutton, MD
Close
Sort by
Journal Articles

A Multicenter, Randomized, Controlled Clinical Pilot Trial of the Feasibility of an Intensive RBC Transfusion Policy for Patients with Acute Leukemia Treated with Induction Chemotherapy or Stem Cell Transplant.

Kathryn E. Webert, MD, Richard J. Cook, PhD, Morris A. Blajchman, MD, Stephen Couban, MD, David M. Sutton, MD, Jeffrey H. Lipton, MD, Julie Carruthers, Joseph Brandwein, MD, Nancy M. Heddle, MSc, FCMLS(D)
Journal: Blood
Blood (2005) 106 (11): 4183.
https://doi.org/10.1182/blood.V106.11.4183.4183
Published: 2005
Journal Articles

A Randomised Controlled Trail of Plasma Exchange in Rapidly Progressive Renal Failure of Myeloma.

William F. Clark, MD, A. Keith Stewart, MD, Gail A. Rock, MD, Marion Sternbach, MD, David M. Sutton, MD, Brendan J. Barrett, MD, Paul A. Heidenheim, MA, David N. Churchill, MD, members of the Canadian Apheresis Group
Journal: Blood
Blood (2004) 104 (11): 4899.
https://doi.org/10.1182/blood.V104.11.4899.4899
Published: 2004
Journal Articles

Negative Impact of Pre-Transplant Anemia on Long-Term Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Chris Lazongas, BSc, Cindy J. Wong, MSc, David M. Sutton, MD, Jeffrey H. Lipton, MD PhD, Anargyros Xenocostas, MD, Hans A. Messner, MD PhD
Journal: Blood
Blood (2004) 104 (11): 1844.
https://doi.org/10.1182/blood.V104.11.1844.1844
Published: 2004